[1]
M. Andabaka, I. Novaković, and J. Drulovic, “SIGNIFICANCE OF MOLECULAR BIOMARKERS IN THE DIAGNOSIS OF NEUROMYELITIS OPTICA SPECTRUM DISORDER”, MedPodml, vol. 76, no. 4, pp. 28–34, May 2024, doi: 10.5937/mp76-48309.